A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID‐19 susceptibility, severity, and long COVID‐19. Issue 1 (3rd November 2022)
- Record Type:
- Journal Article
- Title:
- A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID‐19 susceptibility, severity, and long COVID‐19. Issue 1 (3rd November 2022)
- Main Title:
- A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID‐19 susceptibility, severity, and long COVID‐19
- Authors:
- Moslemi, Camous
Sækmose, Susanne
Larsen, Rune
Brodersen, Thorsten
Didriksen, Maria
Hjalgrim, Henrik
Banasik, Karina
Nielsen, Kaspar R.
Bruun, Mie T.
Dowsett, Joseph
Kasperen, Kathrine A.
Mikkelsen, Susan
Hansen, Thomas F.
Ullum, Henrik
Erikstrup, Christian
Olsson, Martin L.
Ostrowski, Sisse R.
Pedersen, Ole B. - Abstract:
- Abstract: Background: Previous studies have reported Blood type O to confer a lower risk of SARS‐CoV‐2 infection, while secretor status and other blood groups have been suspected to have a similar effect as well. Study design and methods: To determine whether any other blood groups influence testing positive for SARS‐CoV‐2, COVID‐19 severity, or prolonged COVID‐19, we used a large cohort of 650, 156 Danish blood donors with varying available data for secretor status and blood groups ABO, Rh, Colton, Duffy, Diego, Dombrock, Kell, Kidd, Knops, Lewis, Lutheran, MNS, P1PK, Vel, and Yt. Of these, 36, 068 tested positive for SARS‐CoV‐2 whereas 614, 088 tested negative between 2020‐02‐17 and 2021‐08‐04. Associations between infection and blood groups were assessed using logistic regression models with sex and age as covariates. Results: The Lewis blood group antigen Le a displayed strongly reduced SARS‐CoV‐2 susceptibility OR 0.85 CI[0.79–0.93] p < .001. Compared to blood type O, the blood types B, A, and AB were found more susceptible toward infection with ORs 1.1 CI[1.06–1.14] p < .001, 1.17 CI[1.14–1.2] p < .001, and 1.2 CI[1.14–1.26] p < .001, respectively. No susceptibility associations were found for the other 13 blood groups investigated. There was no association between any blood groups and COVID‐19 hospitalization or long COVID‐19. No secretor status associations were found. Discussion: This study uncovers a new association to reduced SARS‐CoV‐2 susceptibility forAbstract: Background: Previous studies have reported Blood type O to confer a lower risk of SARS‐CoV‐2 infection, while secretor status and other blood groups have been suspected to have a similar effect as well. Study design and methods: To determine whether any other blood groups influence testing positive for SARS‐CoV‐2, COVID‐19 severity, or prolonged COVID‐19, we used a large cohort of 650, 156 Danish blood donors with varying available data for secretor status and blood groups ABO, Rh, Colton, Duffy, Diego, Dombrock, Kell, Kidd, Knops, Lewis, Lutheran, MNS, P1PK, Vel, and Yt. Of these, 36, 068 tested positive for SARS‐CoV‐2 whereas 614, 088 tested negative between 2020‐02‐17 and 2021‐08‐04. Associations between infection and blood groups were assessed using logistic regression models with sex and age as covariates. Results: The Lewis blood group antigen Le a displayed strongly reduced SARS‐CoV‐2 susceptibility OR 0.85 CI[0.79–0.93] p < .001. Compared to blood type O, the blood types B, A, and AB were found more susceptible toward infection with ORs 1.1 CI[1.06–1.14] p < .001, 1.17 CI[1.14–1.2] p < .001, and 1.2 CI[1.14–1.26] p < .001, respectively. No susceptibility associations were found for the other 13 blood groups investigated. There was no association between any blood groups and COVID‐19 hospitalization or long COVID‐19. No secretor status associations were found. Discussion: This study uncovers a new association to reduced SARS‐CoV‐2 susceptibility for Lewis type Le a and confirms the previous link to blood group O. The new association to Le a could be explained by a link between mucosal microbiome and SARS‐CoV‐2. … (more)
- Is Part Of:
- Transfusion. Volume 63:Issue 1(2023)
- Journal:
- Transfusion
- Issue:
- Volume 63:Issue 1(2023)
- Issue Display:
- Volume 63, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 63
- Issue:
- 1
- Issue Sort Value:
- 2023-0063-0001-0000
- Page Start:
- 47
- Page End:
- 58
- Publication Date:
- 2022-11-03
- Subjects:
- ABO -- blood antigen -- blood groups -- blood systems -- COVID hospitalization -- COVID severity -- COVID susceptibility -- COVID‐19 -- Diego -- Dombrock -- Duffy -- FUT2 -- FUT3 -- Kell -- Kidd -- Knops -- Lewis -- long COVID symptoms -- long COVID‐19 -- Lutheran -- MNS -- P1PK -- Rh -- SARS‐CoV‐2 -- secretor -- Vel -- Yt
Hematology -- Periodicals
Blood -- Transfusion -- Periodicals
Blood Group Antigens -- Periodicals
Blood Preservation -- Periodicals
Blood Transfusion -- Periodicals
615 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1537-2995 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=trf ↗
http://www.transfusion.org ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/trf.17170 ↗
- Languages:
- English
- ISSNs:
- 0041-1132
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9020.704000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25073.xml